Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
Price:
52.2 CNY
10.01%
Market Closed
Updated:
Apr 29, 2024
Income Statement
Earnings Waterfall
Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co Ltd
|
Revenue
|
1B
CNY
|
|
Cost of Revenue
|
-688.5m
CNY
|
|
Gross Profit
|
313.2m
CNY
|
|
Operating Expenses
|
-214.6m
CNY
|
|
Operating Income
|
98.7m
CNY
|
|
Other Expenses
|
7.2m
CNY
|
|
Net Income
|
105.8m
CNY
|
Income Statement
Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co Ltd
Currency: CNY
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue |
337
N/A
|
589
+75%
|
830
+41%
|
989
+19%
|
1 068
+8%
|
1 088
+2%
|
1 194
+10%
|
1 280
+7%
|
1 417
+11%
|
1 527
+8%
|
1 469
-4%
|
1 347
-8%
|
1 128
-16%
|
1 002
-11%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(177)
|
(305)
|
(420)
|
(502)
|
(552)
|
(571)
|
(669)
|
(732)
|
(834)
|
(924)
|
(894)
|
(858)
|
(751)
|
(688)
|
|
| Gross Profit |
161
N/A
|
284
+77%
|
410
+45%
|
488
+19%
|
517
+6%
|
517
0%
|
525
+2%
|
548
+4%
|
583
+6%
|
603
+3%
|
575
-5%
|
490
-15%
|
377
-23%
|
313
-17%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(56)
|
(95)
|
(137)
|
(163)
|
(163)
|
(161)
|
(189)
|
(184)
|
(215)
|
(229)
|
(244)
|
(236)
|
(213)
|
(215)
|
|
| Selling, General & Administrative |
(45)
|
(74)
|
(99)
|
(118)
|
(108)
|
(107)
|
(126)
|
(119)
|
(140)
|
(145)
|
(172)
|
(164)
|
(161)
|
(169)
|
|
| Research & Development |
(13)
|
(23)
|
(35)
|
(44)
|
(50)
|
(50)
|
(56)
|
(61)
|
(73)
|
(82)
|
(70)
|
(75)
|
(57)
|
(48)
|
|
| Depreciation & Amortization |
0
|
0
|
(6)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
2
|
2
|
3
|
(1)
|
(4)
|
(4)
|
1
|
(4)
|
(2)
|
(2)
|
7
|
2
|
5
|
3
|
|
| Operating Income |
104
N/A
|
188
+81%
|
272
+45%
|
325
+19%
|
354
+9%
|
355
+0%
|
337
-5%
|
364
+8%
|
368
+1%
|
374
+2%
|
331
-12%
|
253
-23%
|
164
-35%
|
99
-40%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
(4)
|
(9)
|
(6)
|
(4)
|
3
|
15
|
13
|
34
|
51
|
43
|
44
|
33
|
18
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
10
|
10
|
10
|
8
|
0
|
0
|
(0)
|
(2)
|
(0)
|
(0)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
1
|
0
|
(1)
|
2
|
1
|
2
|
1
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
104
N/A
|
185
+78%
|
262
+42%
|
328
+25%
|
362
+10%
|
369
+2%
|
361
-2%
|
378
+5%
|
400
+6%
|
423
+6%
|
371
-12%
|
296
-20%
|
196
-34%
|
116
-41%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(14)
|
(26)
|
(37)
|
(47)
|
(49)
|
(50)
|
(50)
|
(51)
|
(56)
|
(55)
|
(45)
|
(36)
|
(19)
|
(11)
|
|
| Income from Continuing Operations |
90
|
159
|
226
|
281
|
313
|
319
|
311
|
327
|
344
|
367
|
326
|
260
|
176
|
106
|
|
| Net Income (Common) |
90
N/A
|
159
+78%
|
226
+42%
|
281
+25%
|
313
+11%
|
319
+2%
|
311
-2%
|
327
+5%
|
344
+5%
|
367
+7%
|
326
-11%
|
260
-20%
|
176
-32%
|
106
-40%
|
|
| EPS (Diluted) |
1.06
N/A
|
1.89
+78%
|
2.49
+32%
|
2.51
+1%
|
2.79
+11%
|
4.55
+63%
|
2.77
-39%
|
2.88
+4%
|
3.07
+7%
|
3.27
+7%
|
2.91
-11%
|
2.32
-20%
|
1.57
-32%
|
0.96
-39%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
